Overview

A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This drug-drug interaction study is being conducted to evaluate the potential effect of Dimebon on the pharmacokinetics on dextromethorphan, a probe substrate of the cytochrome P450 2D6 (CYP2D6) enzyme, after multiple dose administration to healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Collaborator:
Medivation, Inc.
Treatments:
Dextromethorphan